These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 33820549)
1. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis. Ono K; Abe T; Oshita A; Sumi Y; Yano T; Okuda H; Kurayoshi M; Kobayashi T; Ohdan H; Noriyuki T; Nakahara M World J Surg Oncol; 2021 Apr; 19(1):97. PubMed ID: 33820549 [TBL] [Abstract][Full Text] [Related]
2. Beppu's Nomogram Score Is an Independent Prognostic Factor for Colorectal Liver Metastasis Receiving Perioperative Chemotherapy and/or Targeted Therapy. Higuchi A; Aoyama T; Kazama K; Murakawa M; Atsumi Y; Katayama Y; Numata K; Sawazaki S; Numata M; Sato S; Sugano N; Tamagawa H; Mushiake H; Oshima T; Yukawa N; Morinaga S; Rino Y; Masuda M; Shiozawa M In Vivo; 2019; 33(4):1301-1306. PubMed ID: 31280222 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases. Ninomiya M; Emi Y; Motomura T; Tomino T; Iguchi T; Kayashima H; Harada N; Uchiyama H; Nishizaki T; Higashi H; Kuwano H Int J Clin Oncol; 2021 Dec; 26(12):2255-2264. PubMed ID: 34519930 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study. Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190 [TBL] [Abstract][Full Text] [Related]
5. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer? Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329 [TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection. Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685 [TBL] [Abstract][Full Text] [Related]
7. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis]. Bao Q; Wang K; Wang HW; Jin KM; Xing BC Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993 [No Abstract] [Full Text] [Related]
8. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis]. Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169 [No Abstract] [Full Text] [Related]
9. Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer. Ke S; Zhan S; Zhu H; Yan D J BUON; 2018; 23(2):296-301. PubMed ID: 29745068 [TBL] [Abstract][Full Text] [Related]
10. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases. Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714 [TBL] [Abstract][Full Text] [Related]
11. Multicentre study of perioperative Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094 [TBL] [Abstract][Full Text] [Related]
12. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection. Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595 [TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis. Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of neoadjuvant chemotherapy in patients with synchronous colorectal liver metastasis: A propensity score matching comparative study. Ueno M; Komeda K; Kosaka H; Nakai T; Nomi T; Iida H; Tanaka S; Ikoma H; Matsuda K; Hirokawa F; Matsumoto M; Hokuto D; Mori H; Morimura R; Kaibori M; Yamaue H; Kubo S Int J Surg; 2021 Oct; 94():106106. PubMed ID: 34536602 [TBL] [Abstract][Full Text] [Related]
15. Objective Definition and Optimized Strategy for "Biologically Borderline Resectable" Colorectal Liver Metastases. Takamoto T; Nara S; Ban D; Mizui T; Murase Y; Esaki M; Shimada K; Hashimoto T; Makuuchi M World J Surg; 2023 Nov; 47(11):2834-2845. PubMed ID: 37540268 [TBL] [Abstract][Full Text] [Related]
16. Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study. Behrenbruch C; Prabhakaran S; Udayasiri D; Hollande F; Michael M; Hayes I; Heriot A; Knowles B; Thomson B ANZ J Surg; 2021 Jun; 91(6):1196-1202. PubMed ID: 33543551 [TBL] [Abstract][Full Text] [Related]
17. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score. Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351 [TBL] [Abstract][Full Text] [Related]
18. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104 [TBL] [Abstract][Full Text] [Related]
19. A Prognostic Scoring System to Predict Survival Outcome of Resectable Colorectal Liver Metastases in this Modern Era. Liu W; Zhang W; Xu Y; Li YH; Xing BC Ann Surg Oncol; 2021 Nov; 28(12):7709-7718. PubMed ID: 34023948 [TBL] [Abstract][Full Text] [Related]